ConductScience.org, home

Gene · 974

Trials83

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07511114POLATUZUMAB VEDOTINPHASE3ClinicalTrials.gov
NCT07502872POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07499271POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07415980POLATUZUMAB VEDOTINPHASE1/PHASE2ClinicalTrials.gov
NCT07398638POLATUZUMAB VEDOTINPHASE1/PHASE2ClinicalTrials.gov
NCT07397832POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07371923POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07231250POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07184788POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07122609POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07072208POLATUZUMAB VEDOTINClinicalTrials.gov
NCT07070648POLATUZUMAB VEDOTINClinicalTrials.gov
NCT07034508POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07012980POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT07001540POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT06803693POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT06765317POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT06743945POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov
NCT06730542POLATUZUMAB VEDOTINPHASE1ClinicalTrials.gov
NCT06665217POLATUZUMAB VEDOTINPHASE2ClinicalTrials.gov

gene-search-2026-11-11-0.1.0

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/974/trials